Eptifibatide bridging therapy for staged carotid artery stenting and cardiac surgery: Safety and feasibility

M. Travis Caton, Kazim H. Narsinh, Amanda Baker, Matthew R. Amans, Steven W. Hetts, Joseph H. Rapp, James C. Ianuzzi, Elaine Tseng, Warren J. Gasper, Daniel L. Cooke

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: Prophylactic carotid artery stenting (CAS) is an effective strategy to reduce perioperative stroke in patients with severe carotid stenosis who require cardiothoracic surgery (CTS). Staging both procedures (CAS-CTS) during a single hospitalization presents conflicting demands for antiplatelet therapy and the optimal pharmacologic strategy between procedures is not established. The purpose of this study is to present our initial experience with a “bridging” protocol for staged CAS-CTS. Methods: A retrospective review of staged CAS-CTS procedures at a single referral center was performed. All patients had multivessel coronary and/or valvular disease and severe carotid stenosis (>70%). Patients not previously on aspirin were also started on aspirin prior to surgery, followed by eptifibatide during CAS (intraprocedural bolus followed by post-procedural infusion which was continued until the morning of surgery). Pre- and perioperative (30 days) neurologic morbidity and mortality was the primary endpoint. Results: 11 CAS procedures were performed in 10 patients using the protocol. The median duration of eptifibatide bridge therapy was 36 h (range 24–288 h). There was one minor bleeding complication (1/11, 9.1%) and no major bleeding complications during the bridging and post-operative period. There was one post-operative, non-neurologic death and zero perioperative ischemic strokes. Conclusions: For patients undergoing staged CAS-CTS, Eptifibatide bridging therapy is a viable temporary antiplatelet strategy with a favorable safety profile. This strategy enables a flexible range of time-intervals between procedures.

Original languageEnglish
StateAccepted/In press - 2022
Externally publishedYes


  • Eptifibatide
  • antiplatelet therapy
  • carotid stent
  • carotid-coronary revascularization
  • dual antiplatelet
  • endovascular surgery


Dive into the research topics of 'Eptifibatide bridging therapy for staged carotid artery stenting and cardiac surgery: Safety and feasibility'. Together they form a unique fingerprint.

Cite this